![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
As of October 2023, Amedeo had |
Prostate Cancer |
Free Subscription
1 BMC Cancer |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Prostate Cancer is free of charge.
Unveiling poly(rC)-binding protein 2 as the target protein for curcusone C
against prostate cancer: mechanism validation through click chemistry-activity
based proteomics profiling approach.
BMC Cancer. 2023;23:957.
PubMed
Abstract available
Prostate cancer progression relies on the mitotic kinase citron kinase.
Cancer Res. 2023 Oct 6. doi: 10.1158/0008-5472.CAN-23-0883.
PubMed
Abstract available
Bullseye or Tip of the Iceberg: Magnetic Resonance Imaging-visible Disease in
Radiorecurrent Prostate Cancer.
Eur Urol. 2023 Oct 5:S0302-2838(23)03145-7. doi: 10.1016/j.eururo.2023.
PubMed
Re: Jean-Nicolas Cornu, Paul Zantek, Glyn Burtt, et al. Minimally Invasive
Treatments for Benign Prostatic Obstruction: A Systematic Review and Network
Meta-analysis. Eur Urol. 2023;83:534-47.
Eur Urol. 2023;84:e116.
PubMed
Re: Peter Fletcher, Marta De Santis, Simona Ippoliti, et al. Vector Prostate
Biopsy: A Novel Magnetic Resonance Imaging/Ultrasound Image Fusion Transperineal
Biopsy Technique Using Electromagnetic Needle Tracking Under Local Anaesthesia.
Eur Urol 2023
Eur Urol. 2023;84:e114.
PubMed
The real-world outcomes of Lutetium-177 PSMA-617 radioligand therapy in
metastatic castration-resistant prostate cancer: Turkish Oncology Group
multicenter study.
Int J Cancer. 2023 Oct 11. doi: 10.1002/ijc.34749.
PubMed
Abstract available
Tri-modality Therapy with Iodine-125 Brachytherapy, External Beam Radiation
Therapy, and Short- or Long-Term Androgen Deprivation Therapy for High-Risk
Localized Prostate Cancer: Results of a Multicenter, Randomized Phase 3 Trial
(TRIP/TRIGU0907).
Int J Radiat Oncol Biol Phys. 2023 Aug 24:S0360-3016(23)07843.
PubMed
Abstract available
Deep Learning-Based T2-weighted MR Image Quality Assessment and Its Impact on
Prostate Cancer Detection Rates.
J Magn Reson Imaging. 2023 Oct 9. doi: 10.1002/jmri.29031.
PubMed
Abstract available
(177)Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic
Castration-Resistant Prostate Cancer and Prior (223)Ra (RALU Study).
J Nucl Med. 2023 Oct 12:jnumed.123.266125. doi: 10.2967/jnumed.123.266125.
PubMed
Abstract available
Automation, live-cell imaging, and endpoint cell viability for prostate cancer
drug screens.
PLoS One. 2023;18:e0287126.
PubMed
Abstract available
[Early detection of prostate cancer: Towards a new paradigm?].
Prog Urol. 2023 Oct 5:S1166-7087(23)00219-1. doi: 10.1016/j.purol.2023.
PubMed
Abstract available
TP53 structure-function relationships in metastatic castrate-sensitive prostate
cancer and the impact of APR-246 treatment.
Prostate. 2023 Oct 9. doi: 10.1002/pros.24629.
PubMed
Abstract available
Berbamine targets cancer stem cells and reverses cabazitaxel resistance via
inhibiting IGF2BP1 and p-STAT3 in prostate cancer.
Prostate. 2023 Oct 12. doi: 10.1002/pros.24632.
PubMed
Abstract available
Microultrasound in the detection of the index lesion in prostate cancer.
Prostate. 2023 Oct 12. doi: 10.1002/pros.24628.
PubMed
Abstract available
Title: Effect of Transperineal versus Transrectal Prostate Biopsy on the Quality
of Hydrogel Spacer Placement in Men prior to Radiation Therapy for Prostate
Cancer.
Urology. 2023 Oct 5:S0090-4295(23)00858-0. doi: 10.1016/j.urology.2023.
PubMed
Abstract available
The association between low preoperative serum testosterone and post radical
prostatectomy urinary function.
Urology. 2023 Jul 27:S0090-4295(23)00654-4. doi: 10.1016/j.urology.2023.
PubMed
Abstract available
Urologists and Lesbian, Gay, Bisexual, Transgender, or Queer Patients: A
Survey-based Study of the Practice Patterns, Attitudes, and Knowledge Base of
Urologists Toward Their Lesbian, Gay, Bisexual, Transgender, or Queer Patients.
Urology. 2023;179:71-79.
PubMed
Abstract available
Thank you for your interest in scientific medicine.